Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Additionally we are shipping WARS Antibodies (73) and WARS Proteins (24) and many more products for this protein.
Showing 10 out of 24 products:
Human WARS ELISA Kit for Sandwich ELISA - ABIN366223
Bao, Ji, Zhao, Ma, Xie, Na: Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease. in Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013
findings establish WARS as a gene whose mutations may cause distal hereditary motor neuropathy and alter canonical and non-canonical functions of tryptophanyl-tRNA synthetase.
Tryptophanyl-tRNA synthetase expression is up-regulated in patients with rheumatoid arthritis.
Genes within recently identified loci associated with waist-hip ratio (WHR) exhibit fat depot-specific mRNA expression, which correlates with obesity-related traits. Adipose tissue (AT) mRNA expression of 6 genes (TBX15 (show TBX15 ELISA Kits)/WARS2 (show WARS2 ELISA Kits), STAB1 (show STAB1 ELISA Kits), PIGC (show PIGC ELISA Kits), ZNRF3, GRB14 (show GRB14 ELISA Kits))
Indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase may play critical roles in the immune pathogenesis of chronic kidney disease.
Naturally occurring fragments of the two proteins involved in translation, TyrRS (show Yars ELISA Kits) and TrpRS, have opposing activities on angiogenesis.
Tryptophanyl-tRNA synthetase down-regulation by hypoxia may be a factor responsible for low TrpRS in pancreatic tumors with high metastatic ability.
Mini-tryptophanyl-tRNA synthetase inhibited ischemic angiogenesis in rats.
Tryptophanyl-tRNA synthetase is a multidomain protein exhibiting excellent allosteric communication, and this research has provided valuable structural as well as functional insights into the protein.
Low tryptophanyl-tRNA synthetase is associated with recurrence in colorectal cancer.
In this study, we show that a recombinant form of a COOH-terminal fragment of TrpRS is a potent antagonist of vascular endothelial growth factor-induced angiogenesis in a mouse model and of naturally occurring retinal angiogenesis in the neonatal mouse
a VE-cadherin (show CDH5 ELISA Kits)-dependent pathway may link T2-TrpRS to inhibition of new blood vessel formation
TrpRS plays a role in protecting against neurodegeneration is suggested, providing an insight into the pathogenesis and a possible treatment of neurodegenerative diseases.
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. Tryptophanyl-tRNA synthetase (WARS) catalyzes the aminoacylation of tRNA(trp) with tryptophan and is induced by interferon. Tryptophanyl-tRNA synthetase belongs to the class I tRNA synthetase family. Four transcript variants encoding two different isoforms have been found for this gene.
, interferon-induced protein 53
, tryptophan tRNA ligase 1, cytoplasmic
, tryptophan--tRNA ligase, cytoplasmic
, tryptophanyl-tRNA synthetase, cytoplasmic
, tryptophanyl-tRNA synthetase
, Tryptophanyl-tRNA synthetase, cytoplasmic
, tryptophanyl-tRNA synthetase II
, tryptophan-tRNA synthetase